Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models

K. Holubova, T. Nekovarova, J. Pistovcakova, A. Sulcova, A. Stuchlík, K. Vales,

. 2014 ; 8 (-) : 130.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc14064319

Grantová podpora
NT13403 MZ0 CEP - Centrální evidence projektů

A number of studies demonstrated a rapid onset of an antidepressant effect of non-competitive N-methyl-d-aspartic acid receptor (NMDAR) antagonists. Nonetheless, its therapeutic potential is rather limited, due to a high coincidence of negative side-effects. Therefore, the challenge seems to be in the development of NMDAR antagonists displaying antidepressant properties, and at the same time maintaining regular physiological function of the NMDAR. Previous results demonstrated that naturally occurring neurosteroid 3α5β-pregnanolone sulfate shows pronounced inhibitory action by a use-dependent mechanism on the tonically active NMDAR. The aim of the present experiments is to find out whether the treatment with pregnanolone 3αC derivatives affects behavioral response to chronic and acute stress in an animal model of depression. Adult male mice were used throughout the study. Repeated social defeat and forced swimming tests were used as animal models of depression. The effect of the drugs on the locomotor/exploratory activity in the open-field test was also tested together with an effect on anxiety in the elevated plus maze. Results showed that pregnanolone glutamate (PG) did not induce hyperlocomotion, whereas both dizocilpine and ketamine significantly increased spontaneous locomotor activity in the open field. In the elevated plus maze, PG displayed anxiolytic-like properties. In forced swimming, PG prolonged time to the first floating. Acute treatment of PG disinhibited suppressed locomotor activity in the repeatedly defeated group-housed mice. Aggressive behavior of isolated mice was reduced after the chronic 30-day administration of PG. PG showed antidepressant-like and anxiolytic-like properties in the used tests, with minimal side-effects. Since PG combines GABAA receptor potentiation and use-dependent NMDAR inhibition, synthetic derivatives of neuroactive steroids present a promising strategy for the treatment of mood disorders. Highlights: -3α5β-pregnanolone glutamate (PG) is a use-dependent antagonist of NMDA receptors.-We demonstrated that PG did not induce significant hyperlocomotion.-We showed that PG displayed anxiolytic-like and antidepressant-like properties.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14064319
003      
CZ-PrNML
005      
20181026090559.0
007      
ta
008      
140704s2014 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fnbeh.2014.00130 $2 doi
035    __
$a (PubMed)24795582
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Holubová, Kristína $u Institute of Physiology, Academy of Sciences of the Czech Republic , Prague , Czech Republic. $7 xx0278720
245    10
$a Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models / $c K. Holubova, T. Nekovarova, J. Pistovcakova, A. Sulcova, A. Stuchlík, K. Vales,
520    9_
$a A number of studies demonstrated a rapid onset of an antidepressant effect of non-competitive N-methyl-d-aspartic acid receptor (NMDAR) antagonists. Nonetheless, its therapeutic potential is rather limited, due to a high coincidence of negative side-effects. Therefore, the challenge seems to be in the development of NMDAR antagonists displaying antidepressant properties, and at the same time maintaining regular physiological function of the NMDAR. Previous results demonstrated that naturally occurring neurosteroid 3α5β-pregnanolone sulfate shows pronounced inhibitory action by a use-dependent mechanism on the tonically active NMDAR. The aim of the present experiments is to find out whether the treatment with pregnanolone 3αC derivatives affects behavioral response to chronic and acute stress in an animal model of depression. Adult male mice were used throughout the study. Repeated social defeat and forced swimming tests were used as animal models of depression. The effect of the drugs on the locomotor/exploratory activity in the open-field test was also tested together with an effect on anxiety in the elevated plus maze. Results showed that pregnanolone glutamate (PG) did not induce hyperlocomotion, whereas both dizocilpine and ketamine significantly increased spontaneous locomotor activity in the open field. In the elevated plus maze, PG displayed anxiolytic-like properties. In forced swimming, PG prolonged time to the first floating. Acute treatment of PG disinhibited suppressed locomotor activity in the repeatedly defeated group-housed mice. Aggressive behavior of isolated mice was reduced after the chronic 30-day administration of PG. PG showed antidepressant-like and anxiolytic-like properties in the used tests, with minimal side-effects. Since PG combines GABAA receptor potentiation and use-dependent NMDAR inhibition, synthetic derivatives of neuroactive steroids present a promising strategy for the treatment of mood disorders. Highlights: -3α5β-pregnanolone glutamate (PG) is a use-dependent antagonist of NMDA receptors.-We demonstrated that PG did not induce significant hyperlocomotion.-We showed that PG displayed anxiolytic-like and antidepressant-like properties.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nekovářová, Tereza $u Institute of Physiology, Academy of Sciences of the Czech Republic , Prague , Czech Republic. $7 xx0071084
700    1_
$a Pistovčáková, Jana, $u Faculty of Medicine, Department of Pharmacology, Masaryk University , Brno , Czech Republic. $d 1972- $7 mzk2004217471
700    1_
$a Šulcová, Alexandra, $u Central European Institute of Technology, Masaryk University , Brno , Czech Republic. $d 1945- $7 jn20000402920
700    1_
$a Stuchlík, Aleš, $u Institute of Physiology, Academy of Sciences of the Czech Republic , Prague , Czech Republic. $d 1974- $7 xx0014340
700    1_
$a Valeš, Karel $u Institute of Physiology, Academy of Sciences of the Czech Republic , Prague , Czech Republic. $7 xx0070865
773    0_
$w MED00174541 $t Frontiers in behavioral neuroscience $x 1662-5153 $g Roč. 8, č. - (2014), s. 130
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24795582 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20181026091110 $b ABA008
999    __
$a ind $b bmc $g 1031803 $s 863051
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 8 $c - $d 130 $i 1662-5153 $m Frontiers in behavioral neuroscience $n Front Behav Neurosci $x MED00174541
GRA    __
$a NT13403 $p MZ0
LZP    __
$a Pubmed-20140704

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...